I am not surprised... there really isn't anything but clear runway for the next 12 months for MSB... no reason why it shouldn't go for a nice run back up to $2 in the near term.
The only people telling the market to sell are the institutions... their justification is that the trials are at risk of failing, which is like saying the risk of buying Qantas is that their planes could all stop working tomorrow... yes that is a possibility, but would you really change your recommendation on something like that?
Their tree shaking attempt did seem to work for a while... but eventually when the supply starts to dry up at the lows, they will need to buy at higher prices to get their fill.
Add to My Watchlist
What is My Watchlist?
